In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Laboratorios del Dr. Esteve SA

Latest From Laboratorios del Dr. Esteve SA

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device

Deal Watch: Roche/Foundation Medicine Highlights Hyper Deal-Making During J.P. Morgan

Biogen will purchase GSK spinout Convergence to bolster its pain portfolio, while Tekmira and OnCore are merging to create a new company focused on hepatitis B. Two J&J units struck deals during the week in Alzheimer’s and gastrointestinal indications, as Lilly teamed up with Merck and Bristol for combo trials to keep its drugs relevant in the PD-1 world.

BioPharmaceutical Deals

Mundipharma, Esteve sign 'perfect' pain therapy pact

Mundipharma Laboratories, in partnership with Purdue Pharmaceuticals, has signed a collaborative deal with Laboratorios Esteve to develop next-generation pain management products – with Esteve aiming to collect a potential $1bn+ in milestone payments.

Neurology Companies

Scrip100: Life as a One Hit Wonder

The road to pop stardom is littered with chart-topping singers who only ever hit the big time once, leaving everyone wondering "where are they now?" Similarly, the pharma industry has a number of players whose success relies heavily on just one drug. Scrip has used our annual number crunch, the Scrip100, to pick out six "One Hit Wonder" companies – firms with very specific yet successful products on the market – and considered the different paths they have followed after their time in the limelight.

Infectious Diseases Cancer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Laboratorios Esteve SA
  • Esteve Group
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Laboratorios del Dr. Esteve SA
  • Senior Management
  • Albert Esteve, CEO
    Jaume Masana, PhD, Dir., Bus. Dev. & Science
  • Contact Info
  • Laboratorios del Dr. Esteve SA
    Phone: (34) 93 446 6000
    Ave. Mare de Deu de Monserrat 221
    Barcelona, 08041